List view / Grid view
Filter the results
The FDA has accepted an IND application for AG017, a new drug designed to treat the causes of coeliac disease which will soon enter new trials.
The pharmaceutical company has received a complete response letter for its golodirsen injection, which had been submitted for accelerated approval.
A treatment for Centronuclear Myopathies has received Orphan Drug Designation from the FDA and will begin Phase I/II trials.
Project TWENTY21, a nationwide study to investigate medicinal cannabis, has launched in the UK in order to collect data on the therapeutics.
PR001 has received Fast Track Designation from the regulatory body for the treatment of Parkinson’s disease.
A recent report has presented an argument for updating vaccine development during health emergencies to increase efficiency.
A treatment for amyloidosis has been pulled from clinical trials after failing to reach endpoints.
The FDA has given approval to AveXis for the first treatment of paediatric spinal muscular atrophy (SMA).
Researchers have identified a possible association between use of statins and developing type 2 diabetes after following patients for 15 years...
The pharmaceutical drug delivery market could reach $1,694.7 billion by 2023, increasing at a CAGR of 6.4 percent during the period...
Oxford Genetics has won six new licensing deals for its scalable drug and gene therapy manufacturing in the synthetic biology sector...